Skip to main navigation Skip to search Skip to main content

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4

  • Yoo Na Kim
  • , Boram Park
  • , Jae Weon Kim
  • , Byoung Gie Kim
  • , Sang Wun Kim
  • , Hee Seung Kim
  • , Chel Hun Choi
  • , Myong Cheol Lim
  • , Natalie YL Ngoi
  • , David SP Tan
  • , Jung Yun Lee
  • Yonsei University
  • Seoul National University
  • National Cancer Center Korea
  • National University of Singapore
  • National University Hospital

Research output: Contribution to journal › Article › peer-review

22   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science